Optimization Of Neuroprotective Therapy Of Ischemic Stroke In The Acute Period
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 3, Pages 3720-3723
AbstractThe problem of cerebrovascular diseases and stroke is significant not only for clinical neurology, but also for society as a whole. Stroke is the second most common cause of death in many developed countries. In Russia, more than 450 thousand cases of this disease are registered per year, and in the Republic of Uzbekistan there are more than ten thousand cases, the mortality rate in the acute period of stroke in Russia reaches 35%, increasing by another 12-15% by the end of the first year after the stroke. Stroke ranks first among the causes of persistent disability, which necessitates timely drug therapy not only in the acute period of the disease, but also throughout the recovery phase.
- Article View: 99
- PDF Download: 188